Arvind K. Bhargava

434 total citations
18 papers, 366 citations indexed

About

Arvind K. Bhargava is a scholar working on Molecular Biology, Physiology and Materials Chemistry. According to data from OpenAlex, Arvind K. Bhargava has authored 18 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Physiology and 3 papers in Materials Chemistry. Recurrent topics in Arvind K. Bhargava's work include Biochemical and Molecular Research (3 papers), Enzyme Structure and Function (3 papers) and Muscle Physiology and Disorders (2 papers). Arvind K. Bhargava is often cited by papers focused on Biochemical and Molecular Research (3 papers), Enzyme Structure and Function (3 papers) and Muscle Physiology and Disorders (2 papers). Arvind K. Bhargava collaborates with scholars based in United States, Canada and United Kingdom. Arvind K. Bhargava's co-authors include Eric A. Barnard, Martin C. Mahoney, Peter D. McElroy, James R. Marshall, K. Michael Cummings, Michael S. Hudecki, Reid R. Heffner, John G. Jones, Catherine M. Pollina and Michael L. Palmer and has published in prestigious journals such as Nature, Biochemistry and Cancer.

In The Last Decade

Arvind K. Bhargava

18 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arvind K. Bhargava United States	12	144	122	82	49	33	18	366
Ruth N. Harada United States	11	97 0.7×	56 0.5×	27 0.3×	44 0.9×	8 0.2×	18	424
Fred G. Bock United States	15	137 1.0×	63 0.5×	107 1.3×	21 0.4×	49 1.5×	50	567
Manju Mukherjea India	11	203 1.4×	37 0.3×	24 0.3×	29 0.6×	56 1.7×	52	510
Qian Gao China	12	197 1.4×	56 0.5×	47 0.6×	36 0.7×	30 0.9×	33	581
Carol A. Mapes United States	11	96 0.7×	191 1.6×	114 1.4×	20 0.4×	46 1.4×	16	493
Joe R. Wardell United Kingdom	13	121 0.8×	120 1.0×	15 0.2×	28 0.6×	8 0.2×	23	399
Patricia S. Otto United States	7	121 0.8×	20 0.2×	14 0.2×	51 1.0×	28 0.8×	8	352
Orhan Bulay United States	11	102 0.7×	37 0.3×	67 0.8×	46 0.9×	39 1.2×	18	379
Jieying Zhang China	13	165 1.1×	55 0.5×	42 0.5×	37 0.8×	48 1.5×	37	445
Krishna P. Maremanda United States	14	294 2.0×	113 0.9×	99 1.2×	34 0.7×	44 1.3×	19	702

Countries citing papers authored by Arvind K. Bhargava

Since Specialization

Citations

This map shows the geographic impact of Arvind K. Bhargava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arvind K. Bhargava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arvind K. Bhargava more than expected).

Fields of papers citing papers by Arvind K. Bhargava

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arvind K. Bhargava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arvind K. Bhargava. The network helps show where Arvind K. Bhargava may publish in the future.

Co-authorship network of co-authors of Arvind K. Bhargava

This figure shows the co-authorship network connecting the top 25 collaborators of Arvind K. Bhargava. A scholar is included among the top collaborators of Arvind K. Bhargava based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arvind K. Bhargava. Arvind K. Bhargava is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Chan, Daniel W., Roy Beveridge, Arvind K. Bhargava, et al.. (1994). Breast Cancer Marker CA549:A Multicenter Study. American Journal of Clinical Pathology. 101(4). 465–470. 10 indexed citations

Petrelli, Nicholas J., et al.. (1992). The utility of squamous cell carcinoma antigen for the follow-up of patients with squamous cell carcinoma of the anal canal. Cancer. 70(1). 35–39. 22 indexed citations

Cummings, K. Michael, et al.. (1990). Measurement of Current Exposure to Environmental Tobacco Smoke. Archives of Environmental Health An International Journal. 45(2). 74–79. 117 indexed citations

Bhargava, Arvind K., et al.. (1989). Serum levels of cancer‐associated antigen ca‐195 in gastrointestinal cancers and its comparison with ca19‐9. Journal of Clinical Laboratory Analysis. 3(6). 370–377. 14 indexed citations

Chheda, Girish B., et al.. (1988). Isolation and Characterization of 3-(3-Amino-3-Carboxypropyl)Uridine from Human Urine. Nucleosides and Nucleotides. 7(4). 417–429. 11 indexed citations

Patrzyc, Helen B., et al.. (1987). Isolation and Characterization of a Novel Nucleoside from the Urines of Chronic Myelogenous Leukemia Patients. Nucleosides and Nucleotides. 6(3). 597–611. 17 indexed citations

Lane, Warren W., et al.. (1987). Plasma selenium levels in patients with advanced upper gastrointestinal cancer. Cancer. 60(9). 2251–2260. 18 indexed citations

Bolanowska, W., et al.. (1986). Isolation and Characterization of a Novel Nucleoside from Human Cancer Urine. Nucleosides and Nucleotides. 5(3). 253–263. 6 indexed citations

Srivastava, Maya D. & Arvind K. Bhargava. (1986). Expression of Dipeptidylaminopeptidase-IV in Some Human T and B Cell Lines. Acta Haematologica. 76(1). 25–28. 6 indexed citations

10.

Bhargava, Arvind K., et al.. (1984). Comparision of immunologic and enzymatic assay of prostatic acid phosphatase for follow‐up and assessment of clinical status of stage d prostate cancer. Journal of Surgical Oncology. 26(4). 256–259. 2 indexed citations

11.

Hudecki, Michael S., Catherine M. Pollina, Reid R. Heffner, & Arvind K. Bhargava. (1981). Enhanced functional ability in drug-treated dystrophic chickens: Trial results with indomethacin, diphenylhydantoin, and prednisolone. Experimental Neurology. 73(1). 173–185. 19 indexed citations

12.

Fitzpatrick, John M., et al.. (1981). Evaluation of whole blood catalase estimation for diagnosis of malignancy. Journal of Surgical Oncology. 16(1). 37–41. 3 indexed citations

13.

Hudecki, Michael S., et al.. (1979). Delayed functional disability in dystrophic chickens receiving chemotherapy. Muscle & Nerve. 2(1). 57–67. 13 indexed citations

14.

Bhargava, Arvind K., et al.. (1977). Yeast hexokinases. 9. Evidence for a single essential thiol in the yeast hexokinase molecule. Biochemistry. 16(19). 4249–4255. 28 indexed citations

15.

Barnard, Eric A., Arvind K. Bhargava, & Michael S. Hudecki. (1976). Postponement of symptoms of hereditary muscular dystrophy in chickens by 5-hydroxytryptamine antagonists. Nature. 263(5576). 422–424. 25 indexed citations

16.

Bhargava, Arvind K., et al.. (1975). Yeast hexokinases. VIII. Essential thiols of yeast hexokinase. Alkylation by a substrate-like reagent. Biochemistry. 14(11). 2403–2410. 24 indexed citations

17.

Jones, John G., et al.. (1975). Yeast hexokinases. VII. Essential and nonessential thiols of yeast hexokinase. Reactions with iodoacetate and iodoacetamide. Biochemistry. 14(11). 2396–2403. 27 indexed citations

18.

Bhargava, Arvind K. & Eric A. Barnard. (1973). Evolution in the pancreatic chymotrypsinogen series: N-terminal sequence determinations and comparisons. Journal of Molecular Evolution. 2(2-3). 187–198. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact